CleanTech Vanadium Mining Corp. has completed the final tranche of its non-brokered private placement, raising a total of CAD 803,500 by issuing 8,035,000 units at CAD 0.10 each. Each unit includes one common share and one warrant to buy an additional share at CAD 0.15 within three years. Insiders subscribed to 2,800,000 units, and the company issued finder's fees in the form of 12,000 units. The funds raised will be used for general working capital as CleanTech continues its mining operations focused on vanadium and fluorspar resources in the U.S. and Canada.
CleanTech Vanadium Mining Corp. completed its final tranche of private placement raising CAD 803,500. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Sep 30, 2026 02:51 WIB: out of 38 priced US stocks, 17 rose and 21 fell. AngloGold Ashanti Limited (AU) rose 1.77% to USD 94.41 with 99% buy orders and a typical hold time of 48 days. Freeport-McMoRan Inc (FCX) fell 1.75% to USD 70.68 with 96% buy orders and a typical hold time of 69 days. Advanced Drainage Systems Inc (WMS) declined 1.73% to USD 128.52 with a typical hold time of 43 days.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
